Quantbot Technologies LP lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 579.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,613 shares of the medical equipment provider's stock after acquiring an additional 23,551 shares during the quarter. Intuitive Surgical comprises approximately 0.4% of Quantbot Technologies LP's holdings, making the stock its 27th biggest holding. Quantbot Technologies LP's holdings in Intuitive Surgical were worth $13,676,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. RWA Wealth Partners LLC lifted its holdings in shares of Intuitive Surgical by 3.6% during the 1st quarter. RWA Wealth Partners LLC now owns 7,918 shares of the medical equipment provider's stock valued at $3,922,000 after acquiring an additional 275 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Korea Investment CORP lifted its holdings in shares of Intuitive Surgical by 4.4% during the 1st quarter. Korea Investment CORP now owns 315,299 shares of the medical equipment provider's stock valued at $156,158,000 after acquiring an additional 13,388 shares in the last quarter. Aptus Capital Advisors LLC lifted its holdings in Intuitive Surgical by 9.4% in the 1st quarter. Aptus Capital Advisors LLC now owns 47,608 shares of the medical equipment provider's stock worth $23,579,000 after buying an additional 4,091 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock worth $1,798,465,000 after buying an additional 11,988 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.
Intuitive Surgical Trading Up 0.7%
NASDAQ ISRG opened at $480.26 on Monday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market cap of $172.16 billion, a price-to-earnings ratio of 66.98, a price-to-earnings-growth ratio of 5.03 and a beta of 1.59. The company has a 50-day moving average price of $508.75 and a two-hundred day moving average price of $524.77.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the prior year, the firm earned $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on ISRG shares. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and cut their price objective for the stock from $515.00 to $440.00 in a report on Monday, June 9th. Truist Financial boosted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Finally, Barclays cut their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.
Get Our Latest Report on Intuitive Surgical
Insider Activity
In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,839 shares of company stock worth $7,896,972 over the last three months. Corporate insiders own 0.70% of the company's stock.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.